Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms, Triple-Negative|Breast Neoplasm Malignant Female|Radiotherapy Side Effect
Interventions: DRUG: Olaparib|RADIATION: Radiation therapy
Sponsor: Institut Curie
Collaborators: AstraZeneca